Literature DB >> 11041074

Sarcopenia and its implications for the elderly.

R Roubenoff1.   

Abstract

Sarcopenia is the loss of muscle mass and strength with age. Sarcopenia is a part of normal aging, and occurs even in master athletes, although it is clearly accelerated by physical inactivity. Sarcopenia contributes to disability, reduced ability to cope with the stress of a major illness, and to mortality in the elderly. The etiology of sarcopenia is unclear, but several important factors have been identified. These include loss of alpha motor neurons, decline in muscle cell contractility, and several potential humoral factors, such as androgen and estrogen withdrawal and increase in production of catabolic cytokines. Treatment of sarcopenia with progressive resistance training is safe and effective, but dissemination of this technique to the general population has yet to occur. As the number of elderly persons increases exponentially in the new century, a public health approach to prevention and treatment of sarcopenia, based on increasing physical activity at all ages, will be crucial to avoiding an epidemic of disability in the future.

Entities:  

Mesh:

Year:  2000        PMID: 11041074     DOI: 10.1038/sj.ejcn.1601024

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  83 in total

Review 1.  The role of apoptosis in age-related skeletal muscle atrophy.

Authors:  Amie J Dirks; Christiaan Leeuwenburgh
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

2.  Muscle expression of genes associated with inflammation, growth, and remodeling is strongly correlated in older adults with resistance training outcomes.

Authors:  Richard A Dennis; Haiyan Zhu; Patrick M Kortebein; Heather M Bush; Jonathan F Harvey; Dennis H Sullivan; Charlotte A Peterson
Journal:  Physiol Genomics       Date:  2009-05-12       Impact factor: 3.107

Review 3.  Age-related muscle dysfunction.

Authors:  LaDora V Thompson
Journal:  Exp Gerontol       Date:  2008-05-17       Impact factor: 4.032

Review 4.  Molecular inflammation: underpinnings of aging and age-related diseases.

Authors:  Hae Young Chung; Matteo Cesari; Stephen Anton; Emanuele Marzetti; Silvia Giovannini; Arnold Young Seo; Christy Carter; Byung Pal Yu; Christiaan Leeuwenburgh
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

Review 5.  The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging.

Authors:  Asimina Hiona; Christiaan Leeuwenburgh
Journal:  Exp Gerontol       Date:  2007-10-04       Impact factor: 4.032

6.  Predicting fat-free mass index and sarcopenia: a pilot study in community-dwelling older adults.

Authors:  Emily I McIntosh; K Brent Smale; Lori Ann Vallis
Journal:  Age (Dordr)       Date:  2013-01-16

Review 7.  Malnutrition and ageing.

Authors:  M Hickson
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

8.  Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.

Authors:  Riccardo Muglia; Matteo Simonelli; Federico Pessina; Emanuela Morenghi; Pierina Navarria; Pasquale Persico; Elena Lorenzi; Angelo Dipasquale; Marco Grimaldi; Marta Scorsetti; Armando Santoro; Letterio S Politi
Journal:  Eur Radiol       Date:  2020-11-17       Impact factor: 5.315

Review 9.  Exercise, PGC-1alpha, and metabolic adaptation in skeletal muscle.

Authors:  Zhen Yan
Journal:  Appl Physiol Nutr Metab       Date:  2009-06       Impact factor: 2.665

10.  Serum albumin in relation to change in muscle mass, muscle strength, and muscle power in older men.

Authors:  Caryn K Snyder; Jodi A Lapidus; Peggy M Cawthon; Thuy-Tien L Dam; Lynn Y Sakai; Lynn M Marshall
Journal:  J Am Geriatr Soc       Date:  2012-08-20       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.